500124:BOM
Dr Reddy's Laboratories Ltd
₹1,195.10
arrow_upward
+1.28%(+15.10) 1D
Oct 9, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 500124...
Open
₹1,181.30
High
₹1,201.00
Low
₹1,172.70
Mkt. cap
997.09B
Avg. vol.
102.55K
Volume
82.38K
Dividend
0.67%
Quarterly dividend
₹2.00
Ex-dividend date
Jul 10, 2026
P/E ratio
30.90
52-wk high
₹1,414.40
52-wk low
₹1,080.05
EPS
₹38.67
Shares outstanding
166.06M
No. of employees
28K
Open
₹1,181.30
High
₹1,201.00
Low
₹1,172.70
Mkt. cap
997.09B
Avg. vol.
102.55K
Volume
82.38K
Dividend
0.67%
Quarterly dividend
₹2.00
Ex-dividend date
Jul 10, 2026
P/E ratio
30.90
52-wk high
₹1,414.40
52-wk low
₹1,080.05
EPS
₹38.67
Shares outstanding
166.06M
No. of employees
28K
News stories
From web sources and news partners
Yahoo Finance
·
6 hours ago
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
24/7 Wall St.
·
20 hours ago
Why "VOO and Chill" Lost Money for 8 Straight Years: What $100,000 in the S&P 500 Did From 2000 to 2008
Seeking Alpha
·
13 hours ago
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
Investor's Business Daily
·
2 hours ago
Futures: 6 Stocks Near Buy Points; Big Earnings, Inflation Data Due
Profile
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
About Dr Reddy's Laboratories Ltd
CEOErez Israeli
Employees27.5K
Founded1984
HeadquartersHyderabad, Andhra Pradesh, India
SectorPharmaceutical industry
Websitedrreddys.com